Head to head
MedVi vs Gala: GLP-1 Programs Compared (2026)
MedVi $299/mo vs Gala $249/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 7.7 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
On paper, MedVi and Gala sell the same thing: a prescription, a vial and a delivery date. In practice they are priced and staffed on different assumptions.
Where they diverge is the pitch: a genuinely low promotional entry point with 24/7 clinical support behind it at MedVi, against a direct-pay model with dose monitoring included rather than sold as an add-on at Gala.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest 12-month cost
- Gala — $2,148 against $2,592 at MedVi, on each provider's own best published pricing.
- Most support for the money
- Gala — Provider check-ins and dose monitoring included.
- Quickest to start
- Gala — Fully online, no in-office visits, then home delivery.
- Longest public track record
- MedVi — 12,896 patient reviews against 2,870.
MedVi vs Gala: the specification
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| MedVi | Gala | |
|---|---|---|
| Advertised price | $179 promotional first month | From $249/mo, as low as $179/mo on longer plans |
| Rate after promotions | $299/mo | $249/mo |
| Pricing structure | Promotional first month, then standard rate | Cheaper per month the longer you commit |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| State coverage | Not published | Not published |
| How fast you start | Simple online process, no clinic visits | Fully online, no in-office visits |
| Patient reviews | 12,896 | 2,870 |
| eRxDoctor score | 9.2/10 | 7.7/10 |
Cost over a full course of treatment
A first-month price is a customer-acquisition number. The totals below are the honest version, built from the rates each provider publishes.
| MedVi | Gala | |
|---|---|---|
| First month | $179 | $249 |
| Months 2 onward | $299/mo | $249/mo |
| 6-month total | $1,674 | $1,494 |
| 12-month total | $3,468 | $2,988 |
| Best published plan | 3-month plan at $649 — $2,592/yr | longer-term plan at $179/mo — $2,148/yr |
Over a year that is a $444 difference, in Gala's favor. Whether it is the right call depends on whether MedVi gives you $37 a month of something you will use.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
The difference that actually decides it
MedVi leads with a genuinely low promotional entry point with 24/7 clinical support behind it. Gala leads with a direct-pay model with dose monitoring included rather than sold as an add-on. Both are true, and neither is the reason most people end up unhappy with a GLP-1 program.
The reasons they do are duller: a price that moved, a support queue that did not answer, or a medication that was not available at the dose they needed. On those, MedVi is exposed on one thing (the price roughly doubles to $299 once the promotional month ends) and Gala on another (the entry price sits above most compounded competitors unless you commit to a longer term).
Read those two caveats again before the marketing. Choosing a provider is mostly choosing which compromise you are prepared to make.
A closer look at MedVi
MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss. In this pairing, its distinguishing feature is a genuinely low promotional entry point with 24/7 clinical support behind it.
Intake is simple online process, no clinic visits. Fulfillment is fast, free shipping. The commercial terms are promotional first month, then standard rate, published upfront.
Support: 24/7 support from certified medical professionals. The medications on offer are compounded semaglutide.
MedVi pros
- Simple online process with no clinic visits required
- 24/7 support from certified medical professionals
- Clinically dosed compounded semaglutide
- Low promotional first month at $179 including fast, free shipping
MedVi cons
- Compounded medication only, no branded Ozempic or Wegovy
- No published outcome or weight loss guarantee
- Price increases sharply after the first month, $299 for a standalone month
The cost of choosing this over Gala: the price roughly doubles to $299 once the promotional month ends.
How Gala works
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery. What it is really selling here is a direct-pay model with dose monitoring included rather than sold as an add-on.
Getting started means fully online, no in-office visits, after which home delivery. Pricing runs on a cheaper per month the longer you commit basis, published upfront.
Provider check-ins and dose monitoring included. The formulary covers compounded semaglutide and compounded tirzepatide.
Gala pros
- Fully online, no in-office visits required
- Direct-pay model, no insurance or prior authorizations needed
- Provider check-ins and dose monitoring included
Gala cons
- Lower long-term pricing requires a multi-month commitment
- Higher entry price than several compounded competitors
The reservation worth holding, particularly next to MedVi: the entry price sits above most compounded competitors unless you commit to a longer term.
Who should choose MedVi, and who should choose Gala
Choose MedVi if:
- you want to start on their timeline: simple online process, no clinic visits
- delivery works the way you want it to: fast, free shipping
- you would rather use the platform with the longer public record (12,896 reviews)
- you are willing to commit for a term in exchange for a lower effective rate (3-month plan at $649)
Choose Gala if:
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- you want to start on their timeline: fully online, no in-office visits
- delivery works the way you want it to: home delivery
- the monthly rate is the constraint — $249/mo against $299/mo
The trade-offs, stated plainly
On price. Gala is the cheaper program at $249/mo against $299/mo. What Gala gives up for that is the entry price sits above most compounded competitors unless you commit to a longer term; what MedVi charges for is a genuinely low promotional entry point with 24/7 clinical support behind it.
On commitment. MedVi rewards a longer commitment (3-month plan at $649), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On medication. MedVi covers compounded semaglutide; Gala covers compounded semaglutide and compounded tirzepatide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
On clinical contact. 24/7 support from certified medical professionals at MedVi; provider check-ins and dose monitoring included at Gala. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
The clinical evidence, separated from the marketing
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
MedVi vs Gala: common questions
Which is cheaper to start, MedVi or Gala?
MedVi, at $179 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which costs less over a year, MedVi or Gala?
Gala, at roughly $2,148 for twelve months against $2,592 at MedVi, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Are MedVi and Gala legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. MedVi operates on promotional first month, then standard rate with pricing published upfront, Gala on cheaper per month the longer you commit, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Neither MedVi nor Gala penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Is MedVi or Gala better for a first GLP-1 prescription?
If this is your first GLP-1, the question is who answers when nausea arrives on day nine. Gala publishes provider check-ins and dose monitoring included, which is the more useful thing to buy at the start.
Can I switch from MedVi to Gala later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date, and check the refund terms on any prepaid plan first.
Do MedVi and Gala prescribe the same medication?
Both dispense compounded GLP-1 preparations. MedVi lists compounded semaglutide and Gala lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
The verdict
On the numbers, Gala wins the year: $2,148 against $2,592. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
MedVi earns the difference in one situation: when a genuinely low promotional entry point with 24/7 clinical support behind it is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- TrimRx vs MedViBudget vs premium
- Yucca Health vs MedViBudget vs premium
- Gala vs He & She MDCoaching-supported vs medication-only
- Gala vs MaximusBudget vs premium
- Refills vs Elevate HealthHead to head
- LIV Body vs TMatesHead to head
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or Gala, and does not sell treatment. Read our ranking methodology.